Hims & Hers director exercises 3,656 RSUs

Hims & Hers Health director Kare Schultz exercised restricted stock units to acquire additional shares of Class A common stock.

Rhea-AI Filing Summary

Hims & Hers Health director Kare Schultz exercised restricted stock units to acquire additional shares of Class A common stock. On June 11, 2026, 3,656 RSUs were converted into 3,656 shares of Class A common stock at a stated price of $0.00 per share. After this derivative exercise, Schultz directly owns 19,397 shares of Class A common stock. The RSUs represent a contingent right to receive one share of Class A common stock for each unit, subject to continuous service and vesting on the earlier of the 2026 annual meeting of stockholders or June 15, 2026.

Insider Trade Summary

3,656 shares exercised/converted

Exercise 2 txns

Insider Schultz Kare

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	3,656	$0.00	$0.00
Exercise	Class A Common Stock	3,656	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 0 contracts (Direct); Class A Common Stock — 19,397 shares (Direct)

Footnotes (1)

1. F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.

Key Figures

RSUs exercised: 3,656 units Shares acquired from RSUs: 3,656 shares Post-transaction holdings: 19,397 shares +1 more

4 metrics

RSUs exercised 3,656 units Restricted stock units converted on June 11, 2026

Shares acquired from RSUs 3,656 shares Class A common stock received on derivative exercise

Post-transaction holdings 19,397 shares Class A common stock directly owned after transaction

Exercise price per share $0.00 per share Stated price for RSU conversion to common stock

Key Terms

Restricted Stock Units ("RSUs"), Class A Common Stock, derivative exercise/conversion, annual meeting of stockholders

4 terms

Restricted Stock Units ("RSUs") financial

"The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Class A Common Stock financial

"which represent a contingent right to receive one share of Class A Common Stock for each RSU"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

annual meeting of stockholders financial

"the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HIMS director Kare Schultz report on this Form 4?

Kare Schultz reported exercising 3,656 restricted stock units into 3,656 shares of Hims & Hers Class A common stock. The transaction reflects a derivative exercise rather than an open-market purchase or sale, increasing Schultz’s directly held share count.

How many Hims & Hers (HIMS) shares does Kare Schultz own after this transaction?

After the June 11, 2026 transaction, Kare Schultz directly owns 19,397 shares of Hims & Hers Class A common stock. This post-transaction balance reflects the addition of 3,656 shares received from the restricted stock unit conversion.

What type of securities were involved in Kare Schultz’s HIMS Form 4 filing?

The filing involves restricted stock units and Class A common stock of Hims & Hers Health, Inc. Restricted stock units were converted on a one-for-one basis into shares of Class A common stock, according to the reported derivative exercise.

Was Kare Schultz’s HIMS transaction a market purchase or sale of shares?

No, the reported activity was a derivative exercise, not an open-market trade. Restricted stock units were converted into Class A common shares at a stated price of $0.00 per share, increasing direct share ownership without a market buy or sell.

What are the vesting conditions for Kare Schultz’s HIMS restricted stock units?

The restricted stock units vest subject to continuous service and will vest on the earlier of the 2026 annual meeting of stockholders or June 15, 2026. Each vested unit entitles the holder to receive one share of Class A common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 05:13 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schultz Kare

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/11/2026		M		3,656	A	(1)	19,397	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	06/11/2026		M			3,656	(1)	(1)	Class A Common Stock	3,656	$0	0	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Kare Schultz	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)